Keywords
Last Name
Institution

Max W. Sung

TitleASSOCIATE PROFESSOR
InstitutionMount Sinai
DepartmentHematology and Medical Oncology
AddressFifth Avenue @ 100th Street
1st Floor
New York NY 10029
Phone212-241-7902
    Other Positions
    TitleASSISTANT PROFESSOR
    InstitutionMount Sinai
    DepartmentOncological Sciences


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Ohnuma T, Lehrer D, Ren C, Cho SY, Maniar M, Silverman L, Sung M, Gretz HF, Benisovich V, Navada S, Akahoho E, Wilck E, Taft DR, Roboz J, Wilhelm F, Holland JF. Phase 1 study of intravenous rigosertib (ON 01910.Na), a novel benzyl styryl sulfone structure producing G2/M arrest and apoptosis, in adult patients with advanced cancer. Am J Cancer Res. 2013; 3(3):323-38.
      View in: PubMed
    2. Alistar A, Sung M, Kim M, Holcombe RF. Clinical pathways for pancreatic neuroendocrine tumors. J Gastrointest Cancer. 2012 Dec; 43(4):532-40.
      View in: PubMed
    3. Tong CC, Ko EC, Sung MW, Cesaretti JA, Stock RG, Packer SH, Forsythe K, Genden EM, Schwartz M, Lau KH, Galsky M, Ozao-Choy J, Chen SH, Kao J. Phase II trial of concurrent sunitinib and image-guided radiotherapy for oligometastases. PLoS One. 2012; 7(6):e36979.
      View in: PubMed
    4. Chang MY, Rogers SN, Lowe D, Jeong WJ, Cha W, Park KT, Kim DW, Chang H, Sung MW, Kim KH, Kwon TK. The Korean version of the University of Washington Quality of Life Questionnaire for Patients with head and neck cancer, and its use in an initial validation study of 56 patients. Int J Oral Maxillofac Surg. 2012 Oct; 41(10):1201-5.
      View in: PubMed
    5. Ocean AJ, Pennington KL, Guarino MJ, Sheikh A, Bekaii-Saab T, Serafini AN, Lee D, Sung MW, Gulec SA, Goldsmith SJ, Manzone T, Holt M, O'Neil BH, Hall N, Montero AJ, Kauh J, Gold DV, Horne H, Wegener WA, Goldenberg DM. Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial. Cancer. 2012 Nov 15; 118(22):5497-506.
      View in: PubMed
    6. Tagawa ST, Milowsky MI, Jeske S, Mazumdar M, Kung S, Sung M, Lehrer D, Matulich D, Selzer J, Wright JJ, Nanus DM. A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981. Am J Clin Oncol. 2011 Oct; 34(5):443-8.
      View in: PubMed
    7. Kim DR, Park MY, Lee CS, Shim SH, Yoon HI, Lee JH, Sung MW, Kim YS, Lee CT. Combination of vorinostat and adenovirus-TRAIL exhibits a synergistic antitumor effect by increasing transduction and transcription of TRAIL in lung cancer cells. Cancer Gene Ther. 2011 Jul; 18(7):467-77.
      View in: PubMed
    8. Ocean AJ, Christos P, Sparano JA, Matulich D, Kaubish A, Siegel A, Sung M, Ward MM, Hamel N, Espinoza-Delgado I, Yen Y, Lane ME. Phase II trial of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehydethiosemicarbazone plus gemcitabine in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol. 2011 Aug; 68(2):379-88.
      View in: PubMed
    9. Kao J, Packer S, Vu HL, Schwartz ME, Sung MW, Stock RG, Lo YC, Huang D, Chen SH, Cesaretti JA. Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response. Cancer. 2009 Aug 1; 115(15):3571-80.
      View in: PubMed
    10. Koh Y, Kim TM, Jeon YK, Kwon TK, Hah JH, Lee SH, Kim DW, Wu HG, Rhee CS, Sung MW, Kim CW, Kim KH, Heo DS. Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma. Ann Oncol. 2009 Aug; 20(8):1414-9.
      View in: PubMed
    11. Ozao-Choy J, Ma G, Kao J, Wang GX, Meseck M, Sung M, Schwartz M, Divino CM, Pan PY, Chen SH. The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res. 2009 Mar 15; 69(6):2514-22.
      View in: PubMed
    12. Sung MW, Waxman S. Combination of cytotoxic-differentiation therapy with 5-fluorouracil and phenylbutyrate in patients with advanced colorectal cancer. Anticancer Res. 2007 Mar-Apr; 27(2):995-1001.
      View in: PubMed
    13. Schwartz JD, Sung M, Schwartz M, Lehrer D, Mandeli J, Liebes L, Goldenberg A, Volm M. Thalidomide in advanced hepatocellular carcinoma with optional low-dose interferon-alpha2a upon progression. Oncologist. 2005 Oct; 10(9):718-27.
      View in: PubMed
    14. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, Krieger NR, Schwartz ME. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl. 2004 Apr; 10(4):534-40.
      View in: PubMed
    15. Florman S, Bowne W, Kim-Schluger L, Sung MW, Huang R, Fotino M, Thung S, Schwartz M, Miller C. Unresectable squamous cell carcinoma of donor origin treated with immunosuppression withdrawal and liver retransplantation. Am J Transplant. 2004 Feb; 4(2):278-82.
      View in: PubMed
    16. Zhang DY, Wu J, Ye F, Xue L, Jiang S, Yi J, Zhang W, Wei H, Sung M, Wang W, Li X. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res. 2003 Jul 15; 63(14):4037-43.
      View in: PubMed
    17. Cartwright-Alcarese F, Sung MW, Brenner B, Zambodla A, Geduld A, Desjardins L. An interdisciplinary approach to the provision of patient support resources across the oncology care continuum: description of a performance improvement project. J Nurs Care Qual. 2003 Jan-Mar; 18(1):61-72; quiz 3 p following 88.
      View in: PubMed
    18. Schwartz JD, Schwartz M, Mandeli J, Sung M. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol. 2002 Oct; 3(10):593-603.
      View in: PubMed
    19. Sung MW, Chen SH, Thung SN, Zhang DY, Huang TG, Mandeli JP, Woo SL. Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver. Hum Gene Ther. 2002 Apr 10; 13(6):731-43.
      View in: PubMed
    20. Roayaie S, Frischer JS, Emre SH, Fishbein TM, Sheiner PA, Sung M, Miller CM, Schwartz ME. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg. 2002 Apr; 235(4):533-9.
      View in: PubMed
    21. Sung MW, Yeh HC, Thung SN, Schwartz ME, Mandeli JP, Chen SH, Woo SL. Intratumoral adenovirus-mediated suicide gene transfer for hepatic metastases from colorectal adenocarcinoma: results of a phase I clinical trial. Mol Ther. 2001 Sep; 4(3):182-91.
      View in: PubMed
    22. Kim S, Wu HG, Heo DS, Kim KH, Sung MW, Park CI. Advanced hypopharyngeal carcinoma treatment results according to treatment modalities. Head Neck. 2001 Sep; 23(9):713-7.
      View in: PubMed
    23. Sung MW, Lee DW, Kim DY, Lee SJ, Hwang CH, Park SW, Kim KH. Sclerotherapy with picibanil (OK-432) for congenital lymphatic malformation in the head and neck. Laryngoscope. 2001 Aug; 111(8):1430-3.
      View in: PubMed
    24. Yang HJ, Cho YJ, Kim HS, Chang MS, Sung MW, Kim WH. Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck. Head Neck. 2001 Aug; 23(8):629-36.
      View in: PubMed
    25. Zier K, Maddux JM, Johnson K, Sung M, Mandeli J, Eisenbach L, Schwartz M. Surrogate markers of antitumor responses: in vitro activation of T cells by autologous tumor peptides. Clin Cancer Res. 2001 Mar; 7(3 Suppl):818s-821s.
      View in: PubMed
    26. Lee SG, Yoon SJ, Kim CD, Kim K, Lim DS, Yeom YI, Sung MW, Heo DS, Kim NK. Enhancement of adenoviral transduction with polycationic liposomes in vivo. Cancer Gene Ther. 2000 Oct; 7(10):1329-35.
      View in: PubMed
    27. Zier K, Johnson K, Maddux JM, Sung M, Mandeli J, Eisenbach L, Schwartz M. IFNgamma secretion following stimulation with total tumor peptides from autologous human tumors. J Immunol Methods. 2000 Jul 31; 241(1-2):61-8.
      View in: PubMed
    28. Lee SG, Heo DS, Yoon SJ, Jee YS, Kang JO, Kim K, Kim CD, Sung MW, Kim NK. Effect of GM-CSF and IL-2 co-expression on the anti-tumor immune response. Anticancer Res. 2000 Jul-Aug; 20(4):2681-6.
      View in: PubMed
    29. Sung MY, Kim MS, Kim EJ, Yoo JH, Sung MW. CoMed: a real-time collaborative medicine system. Int J Med Inform. 2000 Jul; 57(2-3):117-26.
      View in: PubMed
    30. Sung MW, Lee SG, Yoon SJ, Lee HJ, Heo DS, Kim KH, Koh TY, Choi SH, Park SW, Koo JW, Kwon TY. Cationic liposome-enhanced adenoviral gene transfer in a murine head and neck cancer model. Anticancer Res. 2000 May-Jun; 20(3A):1653-6.
      View in: PubMed
    31. Ky AJ, Sung MW, Milsom JW. Research in colon and rectal cancer, with an emphasis on surgical progress. Dis Colon Rectum. 1999 Nov; 42(11):1369-80.
      View in: PubMed
    32. Hong S, Wu HG, Chie EK, Bang YJ, Heo DS, Kim KH, Sung MW, Park CI. Neoadjuvant chemotherapy and radiation therapy compared with radiation therapy alone in advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 1999 Nov 1; 45(4):901-5.
      View in: PubMed
    33. Ku JL, Kim WH, Lee JH, Park HS, Kim KH, Sung MW, Park JG. Establishment and characterization of human laryngeal squamous cell carcinoma cell lines. Laryngoscope. 1999 Jun; 109(6):976-82.
      View in: PubMed
    34. Kim CD, Sung MW, Lee SJ, Heo DS, Yoon SJ, Kim KH. The effect of prostaglandin and its inhibitor on antibody-dependent cellular cytotoxicity against human squamous cell carcinoma of head and neck. Anticancer Res. 1999 Jan-Feb; 19(1A):455-9.
      View in: PubMed
    35. Heo DS, Yoon SJ, Kim WS, Lee KH, Seol JG, Lee SG, Jung CW, Cho EK, Kim CW, Park MH, Sung MW, Kim KH, Bang YJ, Kim NK. Locoregional response and increased natural killer activity after intratumoral injection of HLA-B7/beta2-microglobulin gene in patients with cancer. Hum Gene Ther. 1998 Sep 20; 9(14):2031-8.
      View in: PubMed
    36. Yoon SJ, Heo DS, Kang JO, Lee SG, Kim CD, Sung MW, Kim NK. Synergistic anti-tumor effects with co-expression of GM-CSF and IFN-gamma in murine tumors. Int J Cancer. 1998 Sep 11; 77(6):907-12.
      View in: PubMed
    37. Shapiro RS, Shafir M, Sung M, Warner R, Glajchen N. Cryotherapy of metastatic carcinoid tumors. Abdom Imaging. 1998 May-Jun; 23(3):314-7.
      View in: PubMed
    38. Whiteside TL, Sung MW, Nagashima S, Chikamatsu K, Okada K, Vujanovic NL. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo. Clin Cancer Res. 1998 May; 4(5):1135-45.
      View in: PubMed
    39. Kim KH, Sung MW, Rhee CS, Koo JW, Koh TY, Lee DW, Heo DS, Park CI. Neoadjuvant chemotherapy and radiotherapy for the treatment of advanced hypopharyngeal carcinoma. Am J Otolaryngol. 1998 Jan-Feb; 19(1):40-4.
      View in: PubMed
    40. Chung JH, Cho KH, Lee DY, Kwon OS, Sung MW, Kim KH, Eun HC. Human oral buccal mucosa reconstructed on dermal substrates: a model for oral epithelial differentiation. Arch Dermatol Res. 1997 Nov; 289(12):677-85.
      View in: PubMed
    41. Fiel MI, Schwartz M, Min AD, Sung MW, Thung SN. Malignant schwannoma of the liver in a patient without neurofibromatosis: a case report and review of the literature. Arch Pathol Lab Med. 1996 Dec; 120(12):1145-7.
      View in: PubMed
    42. Sung MW, Nagashima S, Johnson JT, Van Dongen GA, Whiteside TL. The role of apoptosis in antibody-dependent cell-mediated cytotoxicity against monolayers of human squamous cell carcinoma of the head and neck targets. Cell Immunol. 1996 Jul 10; 171(1):20-9.
      View in: PubMed
    43. Sung MW, Johnson JT, Van Dongen G, Whiteside TL. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells. Int J Cancer. 1996 May 3; 66(3):393-9.
      View in: PubMed
    44. Shafir M, Shapiro R, Sung M, Warner R, Sicular A, Klipfel A. Cryoablation of unresectable malignant liver tumors. Am J Surg. 1996 Jan; 171(1):27-31.
      View in: PubMed
    45. Lin WC, Yasumura S, Suminami Y, Sung MW, Nagashima S, Stanson J, Whiteside TL. Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth. J Immunol. 1995 Nov 15; 155(10):4805-16.
      View in: PubMed
    46. Sung MW, Yasumura S, Johnson JT, Van Dongen GA, Whiteside TL. Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck. Int J Cancer. 1995 Jun 9; 61(6):864-72.
      View in: PubMed
    47. Curtiss SI, Mor E, Schwartz ME, Sung MW, Hytiroglou P, Thung SN, Sheiner PA, Emre S, Miller CM. A rational approach to the use of hepatic transplantation in the treatment of metastatic neuroendocrine tumors. J Am Coll Surg. 1995 Feb; 180(2):184-7.
      View in: PubMed
    48. Schwartz ME, Sheiner P, Mor E, Sung M, Miller CM. Treatment of hepatoma by liver transplantation. Transplant Sci. 1994 Sep; 4(1):1-3; discussion 3-4.
      View in: PubMed
    49. Kim KH, Sung MW, Chung PS, Rhee CS, Park CI, Kim WH. Adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1994 Jul; 120(7):721-6.
      View in: PubMed
    50. Chiodini S, Sung MW, Sheiner P, Mor E, Schwartz ME, Miller CM. Liver transplantation for hepatocellular carcinoma: experience at The Mount Sinai Hospital. Mt Sinai J Med. 1994 Jan; 61(1):37-9.
      View in: PubMed
    51. Banerjee R, Price PM, Sung MW, Karpen S, Acs G. Selective inhibition of hepatitis B virus and human immunodeficiency virus sequence-promoted gene expression by cotransfected poly(I):poly(C). Virology. 1990 Nov; 179(1):410-5.
      View in: PubMed
    52. Sung MW, Bruckner HW, Szabo S, Mitty HA. Extrahepatic obstructive jaundice due to colorectal cancer. Am J Gastroenterol. 1988 Mar; 83(3):267-70.
      View in: PubMed
    53. Glicklich D, Sung MW, Frey M. Renal failure due to lymphomatous infiltration of the kidneys. Report of three new cases and review of the literature. Cancer. 1986 Aug 1; 58(3):748-53.
      View in: PubMed
    Sung's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067